|
|
|
|
 |
 |
|
Intezyne Technologies is an early-stage biotechnology corporation that focuses on the development of advanced, synthetic polymers for targeted drug delivery. Intezyne has designed the proprietary IVECT™ drug delivery platform to specifically target diseased cells, thus improving the success of therapeutic treatment while also minimizing harmful side effects. This modular system can effectively encapsulate and deliver a wide range of therapeutics such as hydrophobic drugs, proteins, and DNA and RNA-based drugs as well as contrast agents to aid in early detection of disease. Utilizing the versatile IVECT™ platform, Intezyne is focusing its initial product development in the area of oncology where the targeted delivery of powerful chemotherapeutics and contrast agents can dramatically improve the diagnosis and treatment of cancer.
|
|
|
